aiminute. ← All AI news
Research 2026-08-19

A general chatbot drove the specialist protein tools itself — and two outside labs confirmed the molecules stick

A general chatbot drove the specialist protein tools itself — and two outside labs confirmed the molecules stick

Anthropic published results on 18 August from a protein design campaign in which Claude was not the designer of molecules so much as the operator of the machinery. It was given 15 protein targets and asked to produce 30 binders for each by driving the publicly available specialist design and co-folding models the field already uses. Two outside companies, Adaptyv Bio and Twist Bioscience, then made the designs and tested them in the lab. From 1,320 designs, 354 confirmed binders came back, covering 14 of the 15 targets, with hit rates of 35.1 percent in one configuration and 22.6 percent in another against an industry norm of 10 to 15 percent. Against one target, RBX1, Claude hit 40 percent where entrants in a public competition managed 3.7 percent. It failed cleanly on two targets, producing nothing at all against maltose-binding protein from 90 attempts. In a separate test, the model read raw NMR and mass spectrometry files and reached the lab's own conclusions, calling a sample 96.4 percent pure where the lab said 96.33. These are Anthropic's own results, not peer-reviewed work, though the wet-lab validation was done by named third parties.

Why it mattersThe interesting claim here is not that AI designed a protein — specialist models have done that for years — but that a general-purpose assistant ran those specialist models well enough to beat the people who normally run them. If that holds up, the scarce skill in a lot of laboratory science stops being the tool and starts being the judgement about which tool to point where, and that is exactly the part a chatbot can now imitate. Treat the numbers with the caution any company deserves when grading its own homework. But 354 molecules that a second and third party physically made and measured is a harder kind of evidence than a benchmark score.
#Health AI#Science & Research

✓ Verified · 2 sources

WhatsApp X Telegram
Read in the app — free, in 9 languages

Related stories

Machine learning read the shape of sick brain cells and picked out nine already-approved drugs that calmed them down
2026-08-21
Given four hours and a GPU to improve the way AI is trained, the best agent scored 0.25 out of 1 — and most never tried
2026-08-21
The agent invented a second person to vouch for its code. A 24-year-old in Texas refused to believe either of them.
2026-08-21
Pew put half a million web pages through a detector: a third of everything published since ChatGPT carries its marks
2026-08-21
The FDA has cleared 1,357 AI medical devices. Three of them have been tested on whether patients live longer or better.
2026-08-20